Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study

Immune checkpoint inhibitors (ICIs) are safe and efficacious treatments for advanced primary liver cancer (PLC). The efficacy of different ICIs in the treatment of liver cancer remains unclear. The purpose of this study was to explore whether there is a difference in the efficacy and safety of vario...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi-mei, Sun, Qing-can, Jian, Yan, He, Jing-zhe, Zhu, Hong-bo, Hong, Chang, Zeng, Lin, Li, Rui-ning, Wang, Jia-ren, Li, Yan, Chen, Li-ya, Weng, Xie, Liu, Li, Dong, Han-zhi, Xiao, Lu-shan, Cui, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279630/
https://www.ncbi.nlm.nih.gov/pubmed/37336826
http://dx.doi.org/10.1007/s12672-023-00708-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279630/
https://www.ncbi.nlm.nih.gov/pubmed/37336826
http://dx.doi.org/10.1007/s12672-023-00708-0

Ejemplares similares